INVESTIGADORES
BARRANTES Francisco Jose
capítulos de libros
Título:
REGULATION OF THE NICOTINIC ACETYLCHOLINE RECEPTOR BY CHOLESTEROL AS A BOUNDARY LIPID
Autor/es:
BARRANTES FJ
Libro:
CHOLESTEROL REGULATION OF ION CHANNELS AND RECEPTORS
Editorial:
John Willey & Sons
Referencias:
Lugar: Hoboken; Año: 2012; p. 183 - 204
Resumen:
The nicotinic
acetylcholine receptor (AChR) protein is the archetype molecule in the Cys-loop
superfamily of rapid ligand-gated ion channels, characterized by mediating fast
intercellular communication in response to endogenous neurotransmitters.
Cholesterol, an abundant lipid in the postsynaptic membrane, influences
structural and functional properties of the receptor protein. A wealth of evidence
stemming from biochemical and biophysical experimental data has disclosed lipid
sites in the AChR transmembrane region, and in particular in the boundary area
surrounding the protein. Cholesterol sites have been more difficult to
characterize. A cholesterol recognition motif, coined ?CARC?, has been recently
identified in the transmembrane regions of AChR subunits that bear extensive
contact with the surrounding lipid, and are thus optimally suited to convey
cholesterol-mediated signaling from the latter. The motif is also found in
other members of the Cys-loop receptors and bacterial homologs, and
significantly in the important superfamily of G protein coupled receptors. The
motif is matched by corresponding functional sites defined by the successful
combination of site-directed mutagenesis and single-channel
electrophysiological data, which have led to the recognition of lipid-sensitive
residues in the transmembrane region and the dissection of their contribution
to ligand binding and channel gating, opening and closing. This cumulative
experimental evidence supports the notion that the interface region between the
protein moiety and the adjacent AChR-vicinal (?shell?, ?boundary? or ?annular?)
lipids is the locus of a variety of pharmacologically relevant processes,
including the action of cholesterol, general and local anesthetics, and other
biologically and pharmacologically relevant molecules.